With the launch of the Eucerin hyaluronic filler epigenetic serum, consumers can now test the results of Beiersdorf’s epigenetics research for themselves. The new product is based on the patented technology for the skin-specific “age clock”. Behind this age clock is an algorithm based on epigenetic patterns that makes it possible to measure the biological age of the skin. The Beiersdorf scientists have identified the active ingredient Epicelline, which is said to turn back the ageing clock of skin cells.

Ageing is not predetermined

The new active ingredient and the resulting product are the result of over 15 years of research. Beiersdorf has been an expert in skin research for over 140 years and recognized the potential of epigenetics early on. For a long time, it was assumed that the way we age was only determined by our genes. However, epigenetic research has repeatedly disproved this. The appearance of our skin – its vitality and firmness, including the formation of wrinkles – is influenced by external factors such as diet, lifestyle, stress and UV radiation.

Reactivating youthfulness

Negative influences and the ageing process itself can deactivate our “youth genes”. All this happens without the genetic information itself being changed. Instead, small chemical molecules are attached to the DNA. This process is known as DNA methylation. After more than 15 years, the scientists succeeded in identifying the epigenetic active ingredient Epicelline in connection with this.

New anti-ageing skin care

The Eucerin hyaluronic filler epigenetic serum now brings the active ingredient to the market. The serum is supplemented with hyaluronic acid, glycine saponin and enoxolone. It promises firmer skin, wrinkle reduction, a lifting effect, firmer facial contours and a visibly rejuvenated appearance.

Source: Beiersdorf